VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD.
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD. Br J Haematol. 2013 Jun; 161(5):659-666.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Drug Evaluation
Female
fms-Like Tyrosine Kinase 3
Gene Duplication
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Male
Protein Kinase Inhibitors
Recurrence
Retrospective Studies
Salvage Therapy
Survival Analysis
Tandem Repeat Sequences
Treatment Outcome
authors with profiles
MICHAEL ANDREEFF
HAGOP M KANTARJIAN
RAJYALAKSHMI LUTHRA
ZEEV ESTROV
JORGE E CORTES
FARHAD RAVANDI-KASHANI
GUILLERMO GARCIA-MANERO
GAUTAM BORTHAKUR
NAVEEN PEMMARAJU
KOICHI TAKAHASHI